Jefferies Raises Price Target on Science Applications Int'l (SAIC) to $68 Following 1Q

Go back to Jefferies Raises Price Target on Science Applications Int'l (SAIC) to $68 Following 1Q

Pre-Open Stock Movers 06/13: (EBIO) (LNKD) (AGIO) Higher; (MRNS) (EMES) (WFT) Lower (more...)

June 13, 2016 9:29 AM EDT

Today's Pre-Open Stock Movers

Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) 95.7% HIGHER; announced that it has entered into an exclusive license agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) relating to Elevens Interleukin-6 (IL-6) technology. Also, submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of EBI-031, a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all known forms of IL-6 cytokine signaling, which may be effective for the treatment of ocular diseases such as... More

Science Applications Int'l (SAIC) Declares $0.31 Quarterly Dividend; 2.2% Yield

June 13, 2016 6:34 AM EDT

Science Applications Int'l (NYSE: SAIC) declared a quarterly dividend of $0.31 per share, or $1.24 annualized.

The dividend will be payable on July 29, 2016, to stockholders of record on July 15, 2016, with an ex-dividend date of July 13, 2016.

The annual yield on the dividend is 2.2... More

Science Applications Int'l (SAIC) Reports Q1 EPS of $0.80

June 13, 2016 6:33 AM EDT

Science Applications Int'l (NYSE: SAIC) reported Q1 EPS of $0.80, versus $0.73 reported last year. Revenue for the quarter came in at $1.21 billion, versus $1.01 billion reported last year.

For earnings history and earnings-related data on Science Applications Int'l (SAIC) click here.

... More